1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS

Bliss GVS Pharma Ltd.

NSE: BLISSGVS | BSE: 506197

Mid-range Performer

Check Buy or Sell

100.95 2.35 (2.38%)

54.93% Fall from 52W High

218.6K NSE+BSE Volume

NSEDec 03, 2021 03:31 PM

Watchlist

Portfolio

Alert

Share

9S
12W
3O
1T
660.2

Operating Revenue TTM Cr

Above industry Median

77.3

Net profit TTM Cr

Above industry Median

11.7

Net Profit Margin TTM %

Above industry Median

20.3

Revenue Growth (TTM)

Above industry Median

11.7

Profit Growth (TTM)

Below industry Median



Documents
All Earnings Calls
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2011
pdf
Annual Report Mar-2010
pdf
21 Aug, 2019 BSE INDIA
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Inve...
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Inve...
pdflink
21 May, 2019 BSE INDIA
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Inve...
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Inve...
pdflink
01 Feb, 2019 BSE INDIA
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Inves...
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Inves...
pdflink
03 Nov, 2018 BSE INDIA
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Investor Presentation
pdflink
09 Aug, 2018 BSE INDIA
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Investor Presentation
pdflink